Smartphone app aims to boost recovery from opioid addiction and depression

NCT ID NCT07673380

Recruiting now Disease control Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study tests a mobile health app called uMAT-R, designed to help Black adults recover from opioid or stimulant use and manage depression or anxiety. Participants are recruited from community treatment centers and use the app to track substance use and mental health symptoms. The trial compares two versions of the app—one with extra community support—to see which better promotes abstinence and reduces symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: uMAT-R mobile health intervention with or without enhanced community engagement
What this could lead to: If effective, this approach could provide a scalable, accessible tool to support recovery from substance use and mental health disorders.
What could go wrong: This is a mid-stage trial with 300 participants, so results may not apply to all groups. The intervention relies on smartphone access and engagement, which may limit its reach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION AND ANXIETY SYMPTOMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression opiate dependence opioid abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEPRESSION AND ANXIETY SYMPTOMS OPIOID USE STIMULANT USE

Contacts and locations

Locations

Washington University School of Medicine
RECRUITING

St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.